Douglass Winthrop Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,288
| Closed | -$218K | – | 246 |
|
|
2017
Q3 | $218K | Sell |
4,288
-1,944
| -31% | -$98.8K | 0.01% | 239 |
|
|
2017
Q2 | $336K | Buy |
6,232
+600
| +11% | +$32.3K | 0.02% | 193 |
|
|
2017
Q1 | $297K | Hold |
5,632
| – | – | 0.02% | 203 |
|
|
2016
Q4 | $271K | Sell |
5,632
-21
| -0.4% | -$1.01K | 0.02% | 203 |
|
|
2016
Q3 | $305K | Hold |
5,653
| – | – | 0.02% | 191 |
|
|
2016
Q2 | $306K | Sell |
5,653
-800
| -12% | -$43.3K | 0.02% | 191 |
|
|
2016
Q1 | $327K | Sell |
6,453
-1,600
| -20% | -$81.1K | 0.02% | 183 |
|
|
2015
Q4 | $406K | Sell |
8,053
-3,424
| -30% | -$173K | 0.03% | 175 |
|
|
2015
Q3 | $552K | Buy |
11,477
+920
| +9% | +$44.2K | 0.04% | 148 |
|
|
2015
Q2 | $609K | Hold |
10,557
| – | – | 0.05% | 157 |
|
|
2015
Q1 | $609K | Buy |
+10,557
| New | +$609K | 0.05% | 157 |
|